Personal stem cells show promise against fatal brain disease
NCT ID NCT05167721
Summary
This study is testing whether stem cells taken from a patient's own fat tissue and injected into their spinal fluid can slow the progression of multiple system atrophy (MSA), a rare and fatal neurological disease. Researchers are comparing two different dosing schedules against a placebo in 71 patients to find the most effective and safe approach. The goal is to control disease progression since there are currently no treatments that can stop MSA from getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.